Abstract
Abstract
Background
Therapeutic use of multipotent mesenchymal stem cells (MSCs) is hampered due to poor growth and limited self-renewal potential. The self-renewal potential of MSCs is also affected during propagation and changes are poorly understood. This study investigated the molecular mechanism involved in the self-renewal of primitive (p) MSCs.
Methods
pMSCs were cultured to low passage (LP), P3, and high passage (HP), P20, in fetal bovine serum medium (FM) and xeno-free medium (XM). The characteristics of LP and HP pMSCs were evaluated for morphology, expression of cell surface markers, doubling time (DT), colony forming efficiency (CFE), proliferation by BrdU assay, telomerase activity and trilineage differentiation. We then examined transcriptome and nucleosome occupancies using RNA-seq and MNase-seq, respectively analyses.
Results
pMSCs grown in FM gradually changed morphology to large elongated cells and showed a significant reduction in the expression of CD90 and CD49f, CFE, proliferation, and telomerase activity. In addition, cells had a greater propensity to differentiate into the adipogenic lineage. In contrast, pMSCs grown in XM maintained small fibroblastoid morphology, self-renewal, and differentiation potential. Transcriptomic analysis showed upregulation of genes involved in self-renewal, cell cycle, and DNA replication in XM-grown pMSCs. Whereas senescence genes were upregulated in cells in FM. MNase-seq analysis revealed less nucleosomal occupancies in self-renewal genes and senescence genes in pMSCs grown in XM and FM, respectively. The expression of selected genes associated with self-renewal, cell cycle, DNA replication, differentiation, and senescence was confirmed by qRT-PCR. These results led us to propose signaling pathways involved in the self-renewal and senescence of pMSCs.
Conclusion
We conclude that the self-renewal potential of pMSCs is controlled by WNT and VEGF/PDGF, but TGFβ and PI3K signaling induce senescence.
Publisher
Research Square Platform LLC
Reference78 articles.
1. Robey P. "Mesenchymal stem cells": fact or fiction, and implications in their therapeutic use.F1000Research. 2017;6.
2. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici M;Cytotherapy,2006
3. Mesenchymal stem cells: Cell therapy and regeneration potential;Brown C;J Tissue Eng Regen Med,2019
4. Isolation and comparative analysis of potential stem/progenitor cells from different regions of human umbilical cord;Beeravolu N;Stem Cell Research,2016
5. Au - Beeravolu N, Au - McKee C, Au - Alamri A, Au - Mikhael S et al. Au - Brown C, Au - Perez-Cruet M,. Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta. JoVE. 2017(122):e55224.